Radius Health. has filed a patent for using PTHrP or analogues like abaloparatide to prevent bone fractures and increase bone mineral density in subjects. The method involves administering abaloparatide followed by alendronate to reduce the risk of non-vertebral bone fractures. GlobalData’s report on Radius Health gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Radius Health Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Radius Health, Microneedles for transdermal drug delivery was a key innovation area identified from patents. Radius Health's grant share as of January 2024 was 33%. Grant share is based on the ratio of number of grants to total number of patents.

Treatment for reducing non-vertebral bone fractures

Source: United States Patent and Trademark Office (USPTO). Credit: Radius Health Inc

A recently filed patent (Publication Number: US20230381283A1) outlines a method for reducing the risk of non-vertebral bone fractures and improving bone mineral density (BMD) in individuals in need of such treatment. The method involves administering 80 µg of abaloparatide via subcutaneous injection for 18 months, followed by oral administration of alendronate at varying doses for an additional six months. The patent specifies that the subject may be a woman, particularly a postmenopausal woman with osteoporosis or high cortical porosity, and the non-vertebral bones targeted for fracture risk reduction include wrist and hip bones.

Furthermore, the patent claims that the method results in an increase in total hip BMD by 2% to 6.5% and an increase in femoral neck BMD by at least 4.5%. The treatment is tailored to individuals with normal BMD or a BMD T-score of at least about -1, indicating its potential efficacy in a wide range of patients. The combination of abaloparatide and alendronate is proposed as a promising approach to address bone health concerns, particularly in postmenopausal women with osteoporosis or high cortical porosity. The patent's detailed claims provide a clear outline of the method's parameters and expected outcomes, offering valuable insights into potential advancements in bone fracture prevention and BMD improvement.

To know more about GlobalData’s detailed insights on Radius Health, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies